Gene-Modified Cell Therapy

Gene-Modified Cell Therapy

Products & Services

Information

From early discovery research to clinical trials and commercial production, our comprehensive support ensures you have the highest quality plasmids tailored to your project's unique needs. Our meticulous attention to detail and commitment to quality control ensures all materials meet the highest standards, facilitating successful downstream applications and paving the way for groundbreaking therapeutic advancements. https://www.aldevron.com/modalities/gene-modified-cell-therapy
Aldevron119Founded in 1998, Aldevron is a global leader in enabling the development of next-generation genomic medicines. As part of Danaher Corporation (NYSE: DHR) family of global science and technology companies, Aldevron empowers scientists and innovators worldwide to advance transformative therapies that are redefining the future of medicine. Aldevron’s expertise and integrated solutions have supported landmark achievements—including playing a key role in manufacturing the world’s first mRNA-based personalized CRISPR therapy. With facilities in Fargo, ND, Madison, WI and Waltham, MA, Aldevron is at the forefront of accelerating scientific discovery and expanding the possibilities of gene editing, gene therapy and other breakthrough modalities. By partnering with leading researchers and organizations, Aldevron is helping to turn the promise of genomic medicine into reality for patients around the globe.

Log in

See all the content and easy-to-use features by logging in or registering!